论文部分内容阅读
由于国内A股已暂停新股上市,为了有效扩张下游业务,沉寂两年的中海化学将上市的目标锁定在香港。
As domestic A-shares have suspended the listing of new shares, in order to effectively expand their downstream businesses, CSPH, which has been quiet for two years, has locked up its target of listing in Hong Kong.